Mouse Monoclonal Anti-SARS Spike Protein IgG |
AB-15710 |
Alpha Diagnostics |
20 ug |
EUR 489.6 |
Human IgG antibody Laboratories manufactures the sars-c0v spike protein reagents distributed by Genprice. The Sars-C0V Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Sars-C0V products are available in stock. Specificity: Sars-C0V Category: Spike Group: Protein
Protein information
SARS Biotinylated Spike RBD Recombinant Protein |
10-212 |
ProSci |
0.1 mg |
EUR 752.1 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS Associated Spike Mosaic S(M) Protein |
20-abx260155 |
Abbexa |
-
EUR 1062.00
-
EUR 410.40
-
EUR 1646.40
|
|
|
SARS Associated Spike Mosaic S(N) Protein |
20-abx260157 |
Abbexa |
-
EUR 1062.00
-
EUR 410.40
-
EUR 1646.40
|
|
|
Recombinant SARS-CoV-2 Spike Protein S1 (Fc tag) |
P1541-10 |
Biovision |
10 µg |
EUR 211.2 |
Recombinant SARS-CoV-2 Spike Protein S1 (Fc tag) |
P1541-50 |
Biovision |
50 µg |
EUR 818.4 |
Recombinant Coronavirus Spike Protein (SARS-CoV-2; ECD) |
P1533-10 |
Biovision |
10 µg |
EUR 235.2 |
Recombinant Coronavirus Spike Protein (SARS-CoV-2; ECD) |
P1533-50 |
Biovision |
50 µg |
EUR 709.2 |
Recombinant SARS-CoV-2 Spike Protein S1 (His-tag) |
P1540-10 |
Biovision |
10 µg |
EUR 211.2 |
Recombinant SARS-CoV-2 Spike Protein S1 (His-tag) |
P1540-50 |
Biovision |
50 µg |
EUR 818.4 |
SARS (IN3) Spike Peptide |
3225P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) SARS (IN3) Spike peptide |
SARS (IN1) Spike Peptide |
3221P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) SARS (IN1) Spike peptide |
SARS (IN2) Spike Peptide |
3223P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) SARS (IN2) Spike peptide |
SARS CoV-2 full length spike protein nanodisc complex |
21-817 |
ProSci |
0.025 mg |
EUR 1968 |
Description: The coronavirus, also known as SARS-CoV-2, enters the cell by using its surface SPIKE. SPIKE is processed on the cell's surface by TMPRSS2, a serine protease. It then subsequently binds to ACE2 a cell surface receptor. The Native SPIKE protein is a trimer that is located in the coronavirus membrane. Therefore to get pure & native SPIKE the trimer needs to be kept intact. Our lab staff achieved this in three different ways: MSP nanodiscs, based on MSP proteins Detergent Mycelles, as you can see here Synthetic nanodiscs |
SARS Coronavirus spike (HSZ-Cc) Recombinant Protein |
20-219 |
ProSci |
0.1 mg |
EUR 726.9 |
Description: SARS Coronavirus spike (HSZ-Cc) Recombinant Protein |
SARS-CoV Spike Antibody |
3225-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
3225-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
3219-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |